Tumor stroma and regulation of cancer development.

Abstract In the past 25 years, a majority of cancer studies have focused on examining functional consequences of activating and/or inactivating mutations in critical genes implicated in cell cycle control. These studies have taught us a great deal about the functions of oncogenes and tumor suppressor genes and the signaling pathways regulating cell proliferation and/or cell death. However, such studies have largely ignored the fact that cancers are heterogeneous cellular entities whose growth is dependent upon reciprocal interactions between genetically altered "initiated" cells and the dynamic microenvironment in which they live. This review highlights the aspects of cancer development that, like organogenesis during embryonic development and tissue repair in adult mammals, are regulated by interactions between epithelial cells, activated stromal cells, and soluble and insoluble components of the extracellular matrix.

[1]  S. M. Saati,et al.  Cataloging altered gene expression in young and senescent cells using enhanced differential display. , 1995, Nucleic acids research.

[2]  H. Tschesche,et al.  Matrix Metalloproteinases Collagenase-2, Macrophage Elastase, Collagenase-3, and Membrane Type 1-Matrix Metalloproteinase Impair Clotting by Degradation of Fibrinogen and Factor XII* , 2000, The Journal of Biological Chemistry.

[3]  D. Gabrilovich,et al.  Immature myeloid cells and cancer-associated immune suppression , 2002, Cancer Immunology, Immunotherapy.

[4]  C. Eng,et al.  From developmental disorder to heritable cancer: it's all in the BMP/TGF-β family , 2003, Nature Reviews Genetics.

[5]  T. Kupper,et al.  Immune surveillance in the skin: mechanisms and clinical consequences , 2004, Nature Reviews Immunology.

[6]  S. Pawlowski,et al.  Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. , 2002, Cancer research.

[7]  L. A. Richards,et al.  Increased mast cell density in invasive melanoma , 1998, Journal of cutaneous pathology.

[8]  D. Hanahan,et al.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.

[9]  Ash A. Alizadeh,et al.  Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.

[10]  M J Bissell,et al.  Tumors are unique organs defined by abnormal signaling and context. , 2001, Seminars in cancer biology.

[11]  Steven A. Rosenberg,et al.  Adoptive-cell-transfer therapy for the treatment of patients with cancer , 2003, Nature Reviews Cancer.

[12]  Mina J Bissell,et al.  The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.

[13]  A. Gudkov Microarray Analysis of p53-Mediated Transcription: Mutli-Thousand Piece Puzzle or Invitation to Collective Thinking? , 2003, Cancer biology & therapy.

[14]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[15]  G. Colditz,et al.  Radial scars in benign breast-biopsy specimens and the risk of breast cancer. , 1999, The New England journal of medicine.

[16]  J. Campisi,et al.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.

[17]  J. Masferrer,et al.  Celecoxib: a specific COX-2 inhibitor with anticancer properties. , 2002, Cancer control : journal of the Moffitt Cancer Center.

[18]  U. Felbor,et al.  Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.

[19]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[20]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[21]  B. Pasche,et al.  Is C-reactive protein an inflammation opsonin that signals colon cancer risk? , 2004, JAMA.

[22]  R. Grénman,et al.  Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. , 1997, Experimental cell research.

[23]  N. Funel,et al.  Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma , 2004, Journal of Clinical Pathology.

[24]  M. Barcellos-Hoff,et al.  Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.

[25]  A. Churg,et al.  Mechanisms in the pathogenesis of asbestosis and silicosis. , 1998, American journal of respiratory and critical care medicine.

[26]  J. Gray,et al.  The genetics and genomics of cancer , 2003, Nature Genetics.

[27]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[28]  F. Fitzpatrick,et al.  Inflammation, carcinogenesis and cancer. , 2001, International immunopharmacology.

[29]  David Botstein,et al.  Systemic and cell type-specific gene expression patterns in scleroderma skin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Salles,et al.  Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. , 1998, Blood.

[31]  K. Kinzler,et al.  Landscaping the Cancer Terrain , 1998, Science.

[32]  P. Autio,et al.  Collagen synthesis in human skin in vivo: modulation by aging, ultraviolet B irradiation and localization. , 1994, Photodermatology, photoimmunology & photomedicine.

[33]  J A Hanley,et al.  Nested caseÐcontrol study of the effects of non- steroidal anti-inflammatory drugs on breast cancer risk and stage , 2000 .

[34]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[35]  J. Samet,et al.  Sleep-disordered Breathing and Hypertension: More Research Is Still Needed , 2000 .

[36]  L. Coussens,et al.  The interplay between innate and adaptive immunity regulates cancer development , 2005, Cancer Immunology, Immunotherapy.

[37]  B. Toole,et al.  Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[38]  V. Sukhatme,et al.  Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. , 1999, Biochemical and biophysical research communications.

[39]  F. Balkwill Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[40]  J. Cerhan,et al.  Association of aspirin and other non‐steroidal anti‐inflammatory drug use with incidence of non‐hodgkin lymphoma , 2003, International journal of cancer.

[41]  K. Alitalo,et al.  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.

[42]  H. Kojima,et al.  Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. , 2000, The European respiratory journal.

[43]  R. López‐Ridaura,et al.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis , 2003, BMC Cancer.

[44]  J. Risteli,et al.  Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  R. Kalluri,et al.  Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth* , 2000, The Journal of Biological Chemistry.

[46]  L. Benjamin,et al.  Angiogenesis: Tumorigenesis and the angiogenic switch , 2003, Nature Reviews Cancer.

[47]  W. Schürch,et al.  Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[48]  R. Kalluri Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[49]  R L Juliano,et al.  Integrin signaling and cell growth control. , 1998, Current opinion in cell biology.

[50]  I. Takanami,et al.  Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma , 2000, Cancer.

[51]  R. Billingham,et al.  Transplantation of Skin Components during Chemical Carcinogenesis with 20-Methylcholanthrene , 1951, British Journal of Cancer.

[52]  J. Wallace,et al.  Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.

[53]  Frank McCormick,et al.  Cancer: Survival pathways meet their end , 2004, Nature.

[54]  J. Quigley,et al.  Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. , 2001, Blood.

[55]  A. Nagler,et al.  Halofuginone: a potent inhibitor of critical steps in angiogenesis progression , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  Drew M. Pardoll,et al.  Vaccines: Spinning molecular immunology into successful immunotherapy , 2002, Nature Reviews Immunology.

[57]  H. Kosmehl,et al.  Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro , 2001, Journal of Cancer Research and Clinical Oncology.

[58]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[59]  L. Coussens,et al.  Matrix Metalloproteinases: Mediators of Tumour-Host Cell Interactions , 2005 .

[60]  S. Okushiba,et al.  Long-term survival after radical resection of advanced pancreatic cancer , 2003, International journal of gastrointestinal cancer.

[61]  P. Khavari,et al.  Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .

[62]  P. Carmeliet Angiogenesis in health and disease , 2003, Nature Medicine.

[63]  G. Bratthauer,et al.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.

[64]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[65]  I. Stamenkovic,et al.  CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. , 2002, Genes & development.

[66]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[67]  B. Fingleton,et al.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.

[68]  P. Rous,et al.  CONDITIONAL NEOPLASMS AND SUBTHRESHOLD NEOPLASTIC STATES , 1941, The Journal of experimental medicine.

[69]  S. Jimi,et al.  Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. , 2000, Human pathology.

[70]  M. Aumailley,et al.  Structure and biological activity of the extracellular matrix , 1998, Journal of Molecular Medicine.

[71]  H. Jick,et al.  Association Between Acetaminophen or Nonsteroidal Antiinflammatory Drugs and Risk of Developing Ovarian, Breast, or Colon Cancer , 2002, Pharmacotherapy.

[72]  M. Hendrix,et al.  Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma , 2003, Nature Reviews Cancer.

[73]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[74]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[75]  R. Kalluri,et al.  Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. , 2002, The American journal of pathology.

[76]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[77]  A J Bailey,et al.  Changes in collagen metabolism in prostate cancer: a host response that may alter progression. , 2001, The Journal of urology.

[78]  F. Mitjans,et al.  Integrin αVβ3 Promotes M21 Melanoma Growth in Human Skin by Regulating Tumor Cell Survival , 1999 .

[79]  P. Szlosarek,et al.  Tumour necrosis factor α: a potential target for the therapy of solid tumours , 2003 .

[80]  F. Kabbinavar,et al.  Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer , 2004, Techniques in Coloproctology.

[81]  Shawn M. Sweeney,et al.  Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen* , 2002, The Journal of Biological Chemistry.

[82]  S. Weiss,et al.  Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.

[83]  D. Edwards,et al.  Metalloproteinases and their inhibitors in angiogenesis , 2003, Expert Reviews in Molecular Medicine.

[84]  D. McDonald,et al.  Microvascular Remodelling In Chronic Airway Inflammation In Mice , 2000, Clinical and experimental pharmacology & physiology.

[85]  S. Phan,et al.  Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. , 2001, Current pharmaceutical design.

[86]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[87]  Nicholas R. English,et al.  Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.

[88]  A. van den Hooff,et al.  Stromal involvement in malignant growth. , 1988 .

[89]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[90]  R. Herbst,et al.  Clinical studies of angiogenesis inhibitors: The university of texas md anderson center trial of human endostatin , 2001, Current oncology reports.

[91]  T. Oshikiri,et al.  Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response , 2003, Journal of surgical oncology.

[92]  G. Dranoff Coordinated tumor immunity , 2003 .

[93]  W. Coleman,et al.  Age-dependent regulation of the tumorigenic potential of neoplastically transformed rat liver epithelial cells by the liver microenvironment. , 1994, Cancer research.

[94]  F. Balkwill Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.

[95]  M. Bissell,et al.  Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression? , 1987, Progress in clinical and biological research.

[96]  D. McDonald,et al.  Significance of blood vessel leakiness in cancer. , 2002, Cancer research.

[97]  J. Risteli,et al.  Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[98]  A. Knudson,et al.  Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.

[99]  M. Bissell,et al.  The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.

[100]  Andrew V. Nguyen,et al.  The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.

[101]  M. Skobe,et al.  Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. , 2001, The American journal of pathology.

[102]  D. Gabrilovich,et al.  Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1 , 2001, The Journal of Immunology.

[103]  E. Giovannucci,et al.  The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[104]  S. Takeno,et al.  Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. , 2003, Oncology reports.

[105]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[106]  B. Evers,et al.  Inflammation and the development of pancreatic cancer. , 2002, Surgical oncology.

[107]  L. Coussens,et al.  Three‐Dimensional Visualization of Blood and Lymphatic Vasculature in Tissue Whole Mounts Using Confocal Microscopy , 2005, Current protocols in cytometry.

[108]  D. Pinkel,et al.  The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.

[109]  J. Mössner,et al.  Genetic aspects of chronic pancreatitis. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[110]  R. Hynes,et al.  Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.

[111]  J. Folkman Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[112]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[113]  G. Colditz,et al.  A prospective study of aspirin use and the risk of pancreatic cancer in women. , 2004, Journal of the National Cancer Institute.

[114]  L. Coussens,et al.  De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. , 2005, Cancer cell.

[115]  L. Coussens,et al.  Extrinsic regulators of epithelial tumor progression: metalloproteinases. , 2000, Current opinion in genetics & development.

[116]  D. Hanahan,et al.  Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. , 1996, The American journal of pathology.

[117]  M. Sporn,et al.  Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. , 1990, Science.

[118]  R. M. Hicks,et al.  Epithelial-stromal interactions in normal and chemical carcinogen-treated adult bladder. , 1977, Cancer research.

[119]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[120]  A. Schor,et al.  Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. , 1988, Journal of cell science.

[121]  R. Kaaks,et al.  Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[122]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[123]  J. Risteli,et al.  Aberrant type I and type III collagen gene expression in human breast cancer in vivo , 1998, The Journal of pathology.

[124]  H. Maeda,et al.  Nitric oxide and oxygen radicals in infection, inflammation, and cancer. , 1998, Biochemistry. Biokhimiia.

[125]  J. Risteli,et al.  Immunohistochemical study of type I collagen and type I pN‐collagen in benign and malignant ovarian neoplasms , 1995, Cancer.

[126]  M J Bissell,et al.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. , 2000, Endocrine-related cancer.

[127]  D. Hanahan,et al.  Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice , 1994, Journal of virology.

[128]  C. Kielty,et al.  The Collagen Family: Structure, Assembly, and Organization in the Extracellular Matrix , 2003 .

[129]  N F Boyd,et al.  Growth factors and stromal matrix proteins associated with mammographic densities. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[130]  Lisa M. Ebert,et al.  A Skin-selective Homing Mechanism for Human Immune Surveillance T Cells , 2004, The Journal of experimental medicine.

[131]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[132]  S. Cingarlini,et al.  Derangement of immune responses by myeloid suppressor cells , 2004, Cancer Immunology, Immunotherapy.

[133]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[134]  D. Ruiter,et al.  Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. , 2001, Investigative Ophthalmology and Visual Science.

[135]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[136]  T. Hsu,et al.  Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[137]  L. Coussens,et al.  Inflammation and matrix metalloproteinases: implications for cancer development , 2004 .

[138]  Matthew Meyerson,et al.  Somatic alterations in the human cancer genome. , 2004, Cancer cell.

[139]  Peter C. Brooks,et al.  New Functions for Non-collagenous Domains of Human Collagen Type IV , 2000, The Journal of Biological Chemistry.

[140]  R. Johnson,et al.  Angiogenesis: the role of the microenvironment in flipping the switch. , 2001, Current opinion in genetics & development.

[141]  L. Benítez-Bribiesca,et al.  The Role of Mast Cell Tryptase in Neoangiogenesis of Premalignant and Malignant Lesions of the Uterine Cervix , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[142]  A. Nagler,et al.  Growth inhibition of prostate cancer xenografts by halofuginone * † , 2002, The Prostate.

[143]  Y. Kawarada,et al.  Tenascin is a stromal marker for epithelial malignancy in the mammary gland. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[144]  Koichi Yamazaki,et al.  CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non‐small cell lung cancers , 2003, Cancer science.

[145]  H. Adami,et al.  Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.

[146]  A. Rademaker,et al.  Stimulation of urinary bladder tumorigenesis by carcinogen-exposed stroma. , 1990, The Journal of urology.

[147]  D. Elder,et al.  Melanoma-stroma interactions: structural and functional aspects. , 2002, The Lancet. Oncology.

[148]  R. Weichselbaum,et al.  Anti-angiogenic cues from vascular basement membrane collagen. , 2000, Cancer research.

[149]  B. Gold,et al.  The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. , 2000, Annual review of microbiology.

[150]  K. Alitalo,et al.  Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis , 2000, Oncogene.

[151]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[152]  Raghu Kalluri,et al.  Cancer without disease , 2004, Nature.

[153]  Robert J. Moore,et al.  An Anti-Tumor Necrosis Factor-α Antibody Inhibits the Development of Experimental Skin Tumors , 2003 .

[154]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[155]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[156]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[157]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[158]  K. O'Byrne,et al.  Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. , 2002, Advances in cancer research.

[159]  S. Tsao,et al.  Sex hormone-induced mammary carcinogenesis in female Noble rats: Expression of TGF-β1 and its receptors, TGF-α, and EGF-R in mammary carcinogenesis , 1999, Breast Cancer Research and Treatment.

[160]  L. G. García Rodríguez,et al.  Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.

[161]  R. Greenblatt,et al.  Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection , 2004, Cancer Research.

[162]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[163]  C. Shea,et al.  Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? , 1994, Journal of cutaneous pathology.

[164]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[165]  L. Hansson,et al.  Aspirin and risk for gastric cancer: a population-based case–control study in Sweden , 2001, British Journal of Cancer.

[166]  Jane Sottile,et al.  Regulation of angiogenesis by extracellular matrix. , 2004, Biochimica et biophysica acta.

[167]  M. Shibuya,et al.  MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.

[168]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[169]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[170]  M. Cotterchio,et al.  Nonsteroidal anti-inflammatory drug use and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[171]  Y. Matsuzaki,et al.  Effect of mast cells on tumor angiogenesis in lung cancer. , 2000, The Annals of thoracic surgery.

[172]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[173]  L. Coussens,et al.  Early neoplastic progression is complement independent. , 2004, Neoplasia.

[174]  C. Berking,et al.  Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. , 2001, Cancer research.

[175]  R. Pierce,et al.  Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.

[176]  Ivan Stamenkovic,et al.  Functional structure and composition of the extracellular matrix , 2003, The Journal of pathology.

[177]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[178]  H. Moses,et al.  Tumor-stroma interactions. , 2005, Current opinion in genetics & development.

[179]  L. Meisner,et al.  A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. , 1997, Gastroenterology.

[180]  J. Folkman,et al.  Fundamental concepts of the angiogenic process. , 2003, Current molecular medicine.

[181]  P. Rous,et al.  THE EXPERIMENTAL DISCLOSURE OF LATENT NEOPLASTIC CHANGES IN TARRED SKIN , 1941, The Journal of experimental medicine.

[182]  R. A. Willis The unusual in tumour pathology. , 1967, Canadian Medical Association journal.

[183]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[184]  K. Cullen,et al.  Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors , 1998, Breast Cancer Research and Treatment.

[185]  E. Vuorio,et al.  The family of collagen genes. , 1990, Annual review of biochemistry.

[186]  R. Kalluri,et al.  Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane* , 2000, The Journal of Biological Chemistry.

[187]  M. Pines,et al.  Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats. , 2002, Journal of hepatology.

[188]  R. DuBois,et al.  Cyclooxygenase-2: a therapeutic target. , 2002, Annual review of medicine.

[189]  L. Coussens,et al.  Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. , 2002, Differentiation; research in biological diversity.

[190]  Elaine Fuchs,et al.  Getting under the skin of epidermal morphogenesis , 2002, Nature Reviews Genetics.

[191]  C. Morrison,et al.  Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets , 2004, Cancer Research.

[192]  L. Aaltonen,et al.  Mutations in the SMAD4/DPC4 gene in juvenile polyposis. , 1998, Science.

[193]  P. Muti The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence. , 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[194]  A. Howell,et al.  Occurrence of a fetal fibroblast phenotype in familial breast cancer , 1986, International journal of cancer.

[195]  Masahiro Inoue,et al.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.

[196]  T. Oshikiri,et al.  Clinical significance of immune cell infiltration within gallbladder cancer , 2003, British Journal of Cancer.

[197]  C. Jackson,et al.  Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium. , 1991, Experimental cell research.

[198]  M. Herlyn,et al.  Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1 , 2001, The Journal of Immunology.

[199]  Saroja Ramanujan,et al.  Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. , 2002, Biophysical journal.

[200]  R. Kalluri,et al.  Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties* , 2000, The Journal of Biological Chemistry.

[201]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[202]  M. Thun,et al.  Inflammation and cancer: an epidemiological perspective. , 2004, Novartis Foundation symposium.

[203]  R. D. de Waal,et al.  Lymphangiogenesis in malignant tumours: does it occur? , 2001, The Journal of pathology.

[204]  R. D. de Waal,et al.  Pathophysiological implications of stroma pattern formation in uveal melanoma , 2003, Journal of cellular physiology.

[205]  Krieg,et al.  Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma? , 1998, The British journal of dermatology.

[206]  J. Nyhus,et al.  Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. , 2002, Cancer research.

[207]  D. Pardoll T cells take aim at cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[208]  B. Hogan,et al.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[209]  D. Pardoll,et al.  Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.

[210]  M. Gleave,et al.  Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. , 1991, Cancer research.

[211]  T. McGaha,et al.  Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism. , 2002, Arthritis and rheumatism.

[212]  L. Coussens,et al.  The tumor microenvironment: a critical determinant of neoplastic evolution. , 2003, European journal of cell biology.

[213]  Hans Clevers,et al.  At the Crossroads of Inflammation and Cancer , 2004, Cell.

[214]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[215]  L. Coussens,et al.  Cancer: An inflammatory link , 2004, Nature.

[216]  A. Eisen,et al.  Enhanced collagenase production by fibroblasts derived from human basal cell carcinomas. , 1979, Cancer research.

[217]  D. Bar-Sagi,et al.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.

[218]  D. Ruiter,et al.  Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. , 2002, Investigative ophthalmology & visual science.

[219]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[220]  J. Samet Does idiopathic pulmonary fibrosis increase lung cancer risk? , 2000, American journal of respiratory and critical care medicine.

[221]  T. McGaha,et al.  Effect of Halofuginone on the Development of Tight Skin (TSK) Syndrome , 2002, Autoimmunity.

[222]  Y. Wong,et al.  Sex hormone‐induced prostatic carcinogenesis in the Noble rat: The role of insulin‐like growth factor‐1 (IGF‐1) and vascular endothelial growth factor (VEGF) in the development of prostate cancer , 1998, The Prostate.

[223]  Markku Santala,et al.  Type I and Type III Collagen Metabolites as Predictors of Clinical Outcome in Epithelial Ovarian Cancer , 1999 .